(Q35767456)

10 August 2017

1 reference

title

Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens (English)

1 reference

10 August 2017

Radhika Nandur

1

1 reference

PubMed ID

15133375

10 August 2017

Kavita Kumar

series ordinal

2

1 reference

PubMed ID

15133375

10 August 2017

Amparo C Villablanca

series ordinal

3

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

Preventive Cardiology

1 reference

10 August 2017

7

1 reference

10 August 2017

2

1 reference

10 August 2017

73-79

1 reference

Postmenopausal hormone therapy and mortality.

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Selective oestrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Selective estrogen receptor modulators: a look ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Selective estrogen receptor modulators (SERMs) in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Clinical efficacy of raloxifene in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Coronary heart disease mortality and adjuvant tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Design and methods of the Raloxifene Use for The Heart (RUTH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Influence of tamoxifen on carotid intima-media thickness in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Vasomotor and vascular effects of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Inhibition of intimal hyperplasia using the selective estrogen receptor modulator raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Endothelial function and menopause: effects of raloxifene administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2006.2527.X

10.1111/J.1520-037X.2006.2527.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15133375